T. de Groot
Katholieke Universiteit Leuven
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by T. de Groot.
Journal of Labelled Compounds and Radiopharmaceuticals | 1998
C. Gilissen; Guy Bormans; T. de Groot; Alfons Verbruggen
N-(2-[18F]fluoroethyl)-N′-methylthiourea ([18F]FEMTU), a fluorine-18 labelled derivative of the hydrogen peroxide scavenger dimethlthiourea (DMTU), has been synthesized by reaction of 2-[18F]fluoroethylamine with methylisothiocyanate. 2-[18F]Fluoroethylamine was obtained in modest radiochemical yields (39±6%, mean±sd, n=5, decay corrected) by nucleophilic substitution with [18F]fluoride on N-[2-(p-toluenesulfonyloxy)ethyl]phthalimide followed by deprotection with hydrazine and distillation. The distilled 2-[18F]fluoroethylamine was trapped in CH2Cl2 and reacted with methyl-isothiocyanate to yield [18F]FEMTU that was purified by reversed phase HPLC. The total synthesis takes 150 min and provides [18F]FEMTU with a specific activity of 3.3±0.5 GBq/μmol (mean±sd, n=3) at end of synthesis, with an overall decay corrected radiochemical yield of 25±8% (mean±sd, n=5).
Journal of Pharmaceutical and Biomedical Analysis | 2003
H Vanbilloen; Bernard Cleynhens; T. de Groot; Alex Maes; Guy Bormans; Alfons Verbruggen
99mTc-TRODAT-1 (technetium(V)-oxo-2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-yl]methyl](2-mercaptoethyl)amino]ethyl]]amino]-ethanethiolato(3-)) and 99mTc-TRODAT-M, the 4-methylphenyl derivative of 99mTc-TRODAT-1, are at this moment being evaluated in clinical trials as imaging agents for the central nervous dopamine transporter system. Both compounds are formed as a mixture of two major diastereomers. As the tracer concentration in preparations for clinical investigations is very low (30-150 pmol/ml), identification of these 99mTc-complexes was, up to now, carried out indirectly using X-ray diffraction analysis of the corresponding rhenium complexes which can be synthesized in gram amounts. In this study, we developed a convenient and practical reversed phase HPLC-method for purification and isolation of the respective diastereomers of 99mTc-TRODAT-1 and three of its derivatives using mixtures of solvents which are compatible with biological studies, i.e. aqueous buffers and ethanol. Furthermore, direct identity confirmation of the 99mTc-complexes using radio-LC-MS was successfully elaborated.
Nuclear Medicine and Biology | 2000
K Mang’era; H Vanbilloen; Bernard Cleynhens; T. de Groot; Guy Bormans; Alfons Verbruggen; Kristin Verbeke
Abstract ABSTRACT. l - Cysteine acetyldiglycine ( l- CAG2), a hybrid compound of l,l- EC and MAG3, and its l -β-homocysteine analogue l- HAG2 were synthesized. After labeling with 99m Tc, 99m Tc- l- CAG2 and 99m Tc- l- HAG2 gave two peaks on high performance liquid chromatography. Urinary excretion of both isomers of 99m Tc- l -CAG2 and 99m Tc- l -HAG2 was slower than for the “parent” complexes 99m Tc-MAG3 or 99m Tc- l,l- EC. Isomer B of 99m Tc- l -CAG2 showed pronounced kidney retention in mice (57% of ID in kidneys at 30 min postinjection), but further evaluation in baboon did not reproduce this phenomenon.
Journal of Labelled Compounds and Radiopharmaceuticals | 1999
C. Gilissen; Guy Bormans; T. de Groot; Alfons Verbruggen
We have prepared two radiolabelled analogues of hemicholinium-3 (HC-3) as potential in vivo tracers of the sodium dependent high affinity choline uptake (SDHAChU) system. Thus, 4-[1-hydroxy-2-(4-[18F]fluoromethylpiperidinyl)ethyl]-4′-[1-hydroxy-2-(4-methylpiperidinyl)ethyl]biphenyl ([18F]FA-4) and 4-[1-hydroxy-2-(4-[11C]methylpiperazinyl)ethyl]-4′-[1-hydroxy-2-(4-methylpiperidinyl)]biphenyl([11C] pipzA-4) have been synthesized. [18F]FA-4 was prepared by reaction of 4-[18F]fluoromethylpiperidine with 4-(α-bromoacetyl)-4′-(4-methylpiperidinylacetyl)-biphenyl followed by reduction of the keto groups to alcohols with NaBH4. The total synthesis time was 300 minutes and [18F]FA-4 was obtained with a specific activity of 5.6 GBq/μmol (EOS) and an overall decay corrected radiochemical yield of 3.1±0.6%. [11C]pipzA-4 was prepared by reaction of [11C]methyl triflate with 4-[1-hydroxy-2-piperazinyl)ethyl]-4′-[1-hydroxy-2-(4-methylpiperidinyl)ethyl]-biphenyl. The total synthesis time was 25 minutes and [11C]pipzA-4 was obtained with a specific activity of 13.7 GBq/μmol (EOS) and an overall decay corrected radiochemical yield of 19.5±2.2%. Copyright
Journal of Labelled Compounds and Radiopharmaceuticals | 2000
Ko Mang'era; Kristin Verbeke; T. de Groot; Guy Bormans; Alfons Verbruggen
Compounds with a monoamine diamide (MADA) thiolate tetraligand structure (L-cysteine acetyldiglycine diethyl ester, L-CAG2D and L-β-methylhomocysteinate acetyldiglycine ethyl ester, L-HAG2ME) were synthesized and labelled with 99m Tc to investigate the 99m Tc-complexation characteristics of these tetraligands On reversed-phase HPLC, 99m Tc-L-CAG2D and 99m Tc-L-HAG2ME each give two peaks, probably isomers. During electrophoresis, all isomers migrate towards the anode indicating a net anionic charge. Octanol-buffer partition coefficients were respectively -0.47 and -0.05 for the isomers of 99m Tc-L-CAG2D and-0.51 and -0.32 for the isomers of 99m Tc-L-HAG2ME. In addition, brain uptake of all HPLC-isolated isomers was low and did not exceed 0.1% of injected dose at 2 min, 10 min or 30 min post injection. It may be concluded that the MADA-type ligands lose their amine proton upon complexation with 99m Tc resulting in hydrophilic, negatively charged 99m Tc-complexes which do not exhibit significant brain uptake in mice.
Journal of Labelled Compounds and Radiopharmaceuticals | 2009
Kim Serdons; Dominique Vanderghinste; M. Van Eeckhoudt; Jan Cleynhens; T. de Groot; Guy Bormans; Alfons Verbruggen
Journal of Labelled Compounds and Radiopharmaceuticals | 2003
Guy Bormans; Bernard Cleynhens; T. de Groot; Luc Mortelmans; Jean-Luc Moretti; Alfons Verbruggen
Journal of Labelled Compounds and Radiopharmaceuticals | 2001
Bernard Cleynhens; H Vanbilloen; Guy Bormans; T. de Groot; Alfons Verbruggen
Journal of Labelled Compounds and Radiopharmaceuticals | 2009
Kim Serdons; Dominique Vanderghinste; M. Van Eeckhoudt; Peter Borghgraef; Hank F. Kung; F. Van Leuven; T. de Groot; Guy Bormans; Alfons Verbruggen
Journal of Labelled Compounds and Radiopharmaceuticals | 2001
T. de Groot; G. Van Oosterwijck; Alfons Verbruggen; Guy Bormans